Utah Medical Products (UTMD) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $0.82.
- Utah Medical Products' EPS (Weighted Average and Diluted) fell 1960.78% to $0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.54, marking a year-over-year decrease of 1709.6%. This contributed to the annual value of $3.96 for FY2024, which is 1334.79% down from last year.
- Utah Medical Products' EPS (Weighted Average and Diluted) amounted to $0.82 in Q3 2025, which was down 1960.78% from $0.94 recorded in Q2 2025.
- In the past 5 years, Utah Medical Products' EPS (Weighted Average and Diluted) ranged from a high of $1.25 in Q4 2022 and a low of $0.82 during Q3 2025
- For the 5-year period, Utah Medical Products' EPS (Weighted Average and Diluted) averaged around $1.04, with its median value being $1.08 (2023).
- Per our database at Business Quant, Utah Medical Products' EPS (Weighted Average and Diluted) soared by 16111.11% in 2021 and then plummeted by 2711.86% in 2024.
- Over the past 5 years, Utah Medical Products' EPS (Weighted Average and Diluted) (Quarter) stood at $1.13 in 2021, then grew by 10.62% to $1.25 in 2022, then decreased by 5.6% to $1.18 in 2023, then dropped by 27.12% to $0.86 in 2024, then decreased by 4.65% to $0.82 in 2025.
- Its last three reported values are $0.82 in Q3 2025, $0.94 for Q2 2025, and $0.92 during Q1 2025.